Media

Oncopeptides provides update on Pepaxto US marketing authorization

Vicore announces first patient enrolled in COMPANION; a digital therapeutic pivotal study for patients with pulmonary fibrosis

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

Priothera – Positive mocravimod Phase 1b clinical data published in Transplantation and Cellular Therapy

Oncopeptides’ Pepaxti has been granted marketing authorization in the UK

Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates

Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement

Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations

Oncopeptides announces the market potential for Pepaxti in Europe